Payment overview · 2025
General Payments
$229.53
3 reported records · 3 companies
Healthcare provider profile · identity verified
Sidney Michael Sutton, MD
Allopathic & Osteopathic Physicians|Family Medicine · ELIZABETH CITY, NC · NPI 1811978158
Verified facts
What the public records show
CMS Open Payments records show Sidney Michael Sutton, MD received $229.53 in general payments during 2025 across 3 reported records.
Novo Nordisk Inc accounted for 43.6% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 101 claims for Ozempic by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $100.00 | 43.6% | 1 | 2025 |
| Agios Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $99.59 | 43.4% | 1 | 2025 |
| ARS Pharmaceuticals Operations, Inc. | Unresolved — no canonical attribution shown | $29.94 | 13.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $229.53 | 3 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Wegovy Normalized: wegovy |
Drug | Novo Nordisk Inc | $100.00 | 1 | 2025 |
Source payment records
|
|||||
| PYRUKYND Normalized: pyrukynd |
Drug | Agios Pharmaceuticals, Inc. | $99.59 | 1 | 2025 |
Source payment records
|
|||||
| NEFFY Normalized: neffy |
Drug | ARS Pharmaceuticals Operations, Inc. | $29.94 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
101 | 23 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Losartan Potassium | Losartan Potassium | 677 | 161 |
| Atorvastatin Calcium | Atorvastatin Calcium | 665 | 164 |
| Amlodipine Besylate | Amlodipine Besylate | 525 | 141 |
| Omeprazole | Omeprazole | 450 | 115 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 442 | 106 |
| Metformin Hcl | Metformin Hcl | 409 | 107 |
| Levothyroxine Sodium | Levothyroxine Sodium | 370 | 79 |
| Metoprolol Succinate | Metoprolol Succinate | 341 | 78 |
| Furosemide | Furosemide | 330 | 89 |
| Gabapentin | Gabapentin | 307 | 77 |
| Eliquis | Apixaban | 293 | 46 |
| Lisinopril | Lisinopril | 281 | 64 |
| Hydrochlorothiazide | Hydrochlorothiazide | 274 | 69 |
| Tamsulosin Hcl | Tamsulosin Hcl | 245 | 61 |
| Pantoprazole Sodium | Pantoprazole Sodium | 244 | 64 |
| Simvastatin | Simvastatin | 243 | 58 |
| Metoprolol Tartrate | Metoprolol Tartrate | 240 | 57 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 226 | 70 |
| Potassium Chloride | Potassium Chloride | 223 | 45 |
| Famotidine | Famotidine | 210 | 58 |
| Tramadol Hcl | Tramadol Hcl | 181 | 59 |
| Glimepiride | Glimepiride | 170 | 43 |
| Carvedilol | Carvedilol | 167 | 50 |
| Dicyclomine Hcl | Dicyclomine Hcl | 166 | 43 |
| Allopurinol | Allopurinol | 155 | 36 |
| Lorazepam | Lorazepam | 155 | 32 |
| Clopidogrel | Clopidogrel Bisulfate | 149 | 40 |
| Montelukast Sodium | Montelukast Sodium | 139 | 32 |
| Prednisone | Prednisone | 126 | 84 |
| Trazodone Hcl | Trazodone Hcl | 126 | 36 |
| Zolpidem Tartrate | Zolpidem Tartrate | 115 | 31 |
| Fluticasone Propionate | Fluticasone Propionate | 113 | 43 |
| Farxiga | Dapagliflozin Propanediol | 108 | 15 |
| Jardiance | Empagliflozin | 108 | 25 |
| Sertraline Hcl | Sertraline Hcl | 108 | 31 |
| Spironolactone | Spironolactone | 104 | 32 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 103 | 25 |
| Ozempic | Semaglutide | 101 | 23 |
| Atenolol | Atenolol | 97 | 23 |
| Escitalopram Oxalate | Escitalopram Oxalate | 97 | 24 |
| Xarelto | Rivaroxaban | 96 | 16 |
| Fluoxetine Hcl | Fluoxetine Hcl | 94 | 22 |
| Alendronate Sodium | Alendronate Sodium | 91 | 21 |
| Bupropion Xl | Bupropion Hcl | 89 | 17 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 85 | 25 |
| Pioglitazone Hcl | Pioglitazone Hcl | 84 | 22 |
| Alprazolam | Alprazolam | 82 | 31 |
| Clonazepam | Clonazepam | 82 | 13 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 81 | 32 |
| Ezetimibe | Ezetimibe | 81 | 17 |
| Quetiapine Fumarate | Quetiapine Fumarate | 81 | 16 |
| Duloxetine Hcl | Duloxetine Hcl | 80 | 23 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 80 | 22 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 80 | 21 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 79 | 15 |
| Diclofenac Sodium | Diclofenac Sodium | 75 | 25 |
| Fenofibrate | Fenofibrate Nanocrystallized | 75 | 14 |
| Synthroid | Levothyroxine Sodium | 75 | 15 |
| Celecoxib | Celecoxib | 73 | 20 |
| Citalopram Hbr | Citalopram Hydrobromide | 73 | 18 |
| Buspirone Hcl | Buspirone Hcl | 69 | 22 |
| Finasteride | Finasteride | 67 | 13 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 65 | 15 |
| Nebivolol Hcl | Nebivolol Hcl | 64 | 16 |
| Hydralazine Hcl | Hydralazine Hcl | 60 | 20 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 60 | 16 |
| Metformin Hcl Er | Metformin Hcl | 56 | 17 |
| Donepezil Hcl | Donepezil Hcl | 54 | 12 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 53 | 14 |
| Januvia | Sitagliptin Phosphate | 53 | 13 |
| Meloxicam | Meloxicam | 53 | 19 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 53 | 15 |
| Meclizine Hcl | Meclizine Hcl | 52 | 23 |
| Ramipril | Ramipril | 51 | suppressed |
| Estradiol | Estradiol | 50 | 20 |
| Amitriptyline Hcl | Amitriptyline Hcl | 49 | suppressed |
| Chlorthalidone | Chlorthalidone | 49 | suppressed |
| Mupirocin | Mupirocin | 49 | 34 |
| Ondansetron Hcl | Ondansetron Hcl | 49 | 17 |
| Pregabalin | Pregabalin | 49 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 49 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 48 | 40 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 48 | 13 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 47 | 21 |
| Ipratropium Bromide | Ipratropium Bromide | 47 | 19 |
| Memantine Hcl | Memantine Hcl | 47 | suppressed |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 44 | 31 |
| Etodolac | Etodolac | 43 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 43 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 42 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 42 | 21 |
| Metoclopramide Hcl | Metoclopramide Hcl | 41 | suppressed |
| Mirtazapine | Mirtazapine | 41 | suppressed |
| Nifedipine Er | Nifedipine | 41 | suppressed |
| Methocarbamol | Methocarbamol | 40 | 12 |
| Sucralfate | Sucralfate | 40 | 16 |
| Ibuprofen | Ibuprofen | 39 | 15 |
| Oxycodone Hcl | Oxycodone Hcl | 39 | suppressed |
| Azithromycin | Azithromycin | 38 | 36 |
| Topiramate | Topiramate | 38 | suppressed |
| Boostrix Tdap | Diphth,pertuss(Acell),tet Vac | 37 | 37 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 37 | 12 |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 36 | 36 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 36 | 19 |
| Warfarin Sodium | Warfarin Sodium | 36 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 35 | suppressed |
| Ketoconazole | Ketoconazole | 35 | 22 |
| Tizanidine Hcl | Tizanidine Hcl | 35 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 34 | suppressed |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 34 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 34 | suppressed |
| Bumetanide | Bumetanide | 33 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 32 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 31 | suppressed |
| Klor-Con M20 | Potassium Chloride | 31 | suppressed |
| Mounjaro | Tirzepatide | 31 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 30 | 13 |
| Bupropion Hcl Sr | Bupropion Hcl | 29 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 29 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 29 | suppressed |
| Verapamil Er | Verapamil Hcl | 29 | suppressed |
| Cephalexin | Cephalexin | 28 | 22 |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 28 | suppressed |
| Fluconazole | Fluconazole | 28 | 19 |
| Lansoprazole | Lansoprazole | 28 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 28 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 28 | suppressed |
| Temazepam | Temazepam | 28 | suppressed |
| Diazepam | Diazepam | 27 | suppressed |
| Novolog Flexpen | Insulin Aspart | 27 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 27 | suppressed |
| Valsartan | Valsartan | 27 | suppressed |
| Lactulose | Lactulose | 26 | suppressed |
| Levetiracetam | Levetiracetam | 26 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 26 | 19 |
| Amiodarone Hcl | Amiodarone Hcl | 25 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 25 | suppressed |
| Trospium Chloride | Trospium Chloride | 25 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 24 | suppressed |
| Invokana | Canagliflozin | 24 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 24 | 20 |
| Nystatin | Nystatin | 24 | 15 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 23 | 18 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 23 | suppressed |
| Ondansetron Odt | Ondansetron | 23 | 14 |
| Propranolol Hcl | Propranolol Hcl | 23 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 22 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 21 | suppressed |
| Rivastigmine | Rivastigmine | 21 | suppressed |
| Sotalol | Sotalol Hcl | 21 | suppressed |
| Telmisartan-Hydrochlorothiazid | Telmisartan/Hydrochlorothiazid | 21 | suppressed |
| Entresto | Sacubitril/Valsartan | 20 | suppressed |
| Levemir Flexpen | Insulin Detemir | 20 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 20 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 20 | suppressed |
| Amoxicillin | Amoxicillin | 19 | 16 |
| Colesevelam Hcl | Colesevelam Hcl | 19 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 19 | suppressed |
| Nitroglycerin | Nitroglycerin | 19 | 16 |
| Aripiprazole | Aripiprazole | 18 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 18 | suppressed |
| Victoza 3-Pak | Liraglutide | 18 | suppressed |
| Dutasteride | Dutasteride | 17 | suppressed |
| Famciclovir | Famciclovir | 17 | suppressed |
| Fenofibrate | Fenofibrate | 17 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 17 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 17 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 17 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 17 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 16 | 13 |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 16 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 16 | suppressed |
| Nystop | Nystatin | 16 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 16 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 15 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 15 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 15 | suppressed |
| Glipizide | Glipizide | 15 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 15 | suppressed |
| Linzess | Linaclotide | 15 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 15 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 15 | suppressed |
| Hydroxyurea | Hydroxyurea | 14 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 14 | suppressed |
| Myrbetriq | Mirabegron | 14 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 14 | suppressed |
| Triazolam | Triazolam | 14 | suppressed |
| Trulicity | Dulaglutide | 14 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 14 | suppressed |
| Armodafinil | Armodafinil | 13 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 13 | suppressed |
| Nyamyc | Nystatin | 13 | suppressed |
| Telmisartan | Telmisartan | 13 | suppressed |
| Xtampza Er | Oxycodone Myristate | 13 | suppressed |
| Atomoxetine Hcl | Atomoxetine Hcl | 12 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 12 | suppressed |
| Fenofibric Acid | Fenofibric Acid (Choline) | 12 | suppressed |
| Irbesartan | Irbesartan | 12 | suppressed |
| Levofloxacin | Levofloxacin | 12 | 11 |
| Livalo | Pitavastatin Calcium | 12 | suppressed |
| Multaq | Dronedarone Hcl | 12 | suppressed |
| Novolin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 12 | suppressed |
| Olmesartan-Amlodipine-Hctz | Olmesartan/Amlodipin/Hcthiazid | 12 | suppressed |
| Rabeprazole Sodium | Rabeprazole Sodium | 12 | suppressed |
| Scopolamine | Scopolamine | 12 | suppressed |
| Theophylline Er | Theophylline Anhydrous | 12 | suppressed |
| Ursodiol | Ursodiol | 12 | suppressed |
| Baclofen | Baclofen | 11 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 11 | suppressed |
| Cartia Xt | Diltiazem Hcl | 11 | suppressed |
| Constulose | Lactulose | 11 | suppressed |
| Dilt-Xr | Diltiazem Hcl | 11 | suppressed |
| Methylphenidate Er | Methylphenidate Hcl | 11 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 11 | suppressed |
| Nitroglycerin Patch | Nitroglycerin | 11 | suppressed |
| Novofine Autocover | Pen Needle, Diabetic, Safety | 11 | suppressed |
| Otezla | Apremilast | 11 | suppressed |
| Spironolactone-Hctz | Spironolact/Hydrochlorothiazid | 11 | suppressed |
| Tiadylt Er | Diltiazem Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $229.53 · 3 records | Novo Nordisk Inc | NEFFY, PYRUKYND, Wegovy | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with Novo Nordisk Inc?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error